|
Professionals in pain management often have
special challenges and the Academy is here to help. Below are
several documents which will aid professionals in their practice-specific
challenges.
In response to the DEA's Interim Policy Statement
(IPS) issued in the November 16, 2004 Federal
Register, the American Academy of Management has
submitted a written response. (link above).
In response to the DEA's Interim Policy Statement (IPS) issued in
the November 16, 2004 Federal Register, the University of Wisconsin Pain & Policy Studies Group has
submitted a written response. A PDF version of the letter, as well as the sequence of events prior to this
response, is available (link above).
It is essential for prescribers of
controlled substances to understand that there are risks
associated with prescribing these agents and that it is essential
to have rigorous adherence to state and federal controlled
substance rules and regulations. This article describes three "sting"
techniques used by law enforcement to induce practitioners to prescribe
controlled substances without appropriate evaluations. Issues concerning
medication diversion, post-dating prescriptions, destruction of medication
and similar topics are additionally discussed.
Prescribers are increasingly in need of agreements
to manage patients with controlled substances over time. This
document provides background information about opioid agreements,
provides a model agreement to use and has many other resource
components.
The linked article provides prescribers with
current information about prescribing controlled substances.
Problems that have gotten other practitioners into trouble are
initially discussed, followed by practical suggestions for staying
out of trouble with regulators. Other prescribing related links
are mentioned in the article.
This document is very helpful for documenting
the authenticity of prospective patients. Unlike typical opioid
agreements this Treatment Attestation form necessitates patients
to make formal declarations about the truthfulness of information
provided, willingness to work with the prescribing practitioner,
and establishes their intent to obtain treatment only for personal
health matters.
Prescribers often need to dispose of controlled
medications. This short article from the KY Board of Medical
Licensure reviews best practices for disposing of returned medications
from patients, office stocked medications and pharmaceutical
samples. Use of a tracking document, having consistent policies,
and adhering to DEA and EPA regulations are emphasized in the
article. Contact numbers are provided through a web link to DEA
registered reverse distributors who remove controlled substances
from practitioners' offices for incineration.
|
